S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in
LON:SN

Smith & Nephew plc (SN.L) Share Forecast, Price & News

GBX 1,577
-10.50 (-0.66 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
1,561.50
Now: GBX 1,577
1,585.50
50-Day Range
1,510
MA: GBX 1,539.24
1,624.50
52-Week Range
1,055.01
Now: GBX 1,577
2,023
Volume1.39 million shs
Average Volume343,671 shs
Market Capitalization£13.83 billion
P/E Ratio35.36
Dividend Yield1.84%
BetaN/A
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers knee implant products for specialized knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Smith & Nephew plc (SN.L) logo

MarketRank

Overall MarketRank

1.20 out of 5 stars

Analyst Opinion: 2.1Community Rank: 2.2Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-74017646
Employees17,500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£4.69 billion
Cash FlowGBX 38.85 per share
Book ValueGBX 570.40 per share

Profitability

Miscellaneous

Market Cap£13.83 billion
Next Earnings Date2/18/2021 (Estimated)
OptionableOptionable
GBX 1,577
-10.50 (-0.66 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SN News and Ratings via Email

Sign-up to receive the latest news and ratings for SN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Smith & Nephew plc (SN.L) (LON:SN) Frequently Asked Questions

How has Smith & Nephew plc (SN.L)'s stock been impacted by Coronavirus (COVID-19)?

Smith & Nephew plc (SN.L)'s stock was trading at GBX 1,506 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SN shares have increased by 4.7% and is now trading at GBX 1,577.
View which stocks have been most impacted by COVID-19
.

Is Smith & Nephew plc (SN.L) a buy right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew plc (SN.L) in the last year. There are currently 1 sell rating, 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Smith & Nephew plc (SN.L) stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SN, but not buy additional shares or sell existing shares.
View analyst ratings for Smith & Nephew plc (SN.L)
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Smith & Nephew plc (SN.L)?

Wall Street analysts have given Smith & Nephew plc (SN.L) a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Smith & Nephew plc (SN.L) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Smith & Nephew plc (SN.L)'s next earnings date?

Smith & Nephew plc (SN.L) is scheduled to release its next quarterly earnings announcement on Thursday, February 18th 2021.
View our earnings forecast for Smith & Nephew plc (SN.L)
.

How often does Smith & Nephew plc (SN.L) pay dividends? What is the dividend yield for Smith & Nephew plc (SN.L)?

Smith & Nephew plc (SN.L) announced a dividend on Wednesday, July 29th. Shareholders of record on Thursday, October 1st will be given a dividend of GBX 0.14 per share on Wednesday, October 28th. This represents a dividend yield of 0.68%. The ex-dividend date of this dividend is Thursday, October 1st. The official announcement can be accessed at this link.
View Smith & Nephew plc (SN.L)'s dividend history
.

Is Smith & Nephew plc (SN.L) a good dividend stock?

Smith & Nephew plc (SN.L) pays an annual dividend of GBX 30 per share and currently has a dividend yield of 1.84%. The dividend payout ratio of Smith & Nephew plc (SN.L) is 67.26%. This payout ratio is at a healthy, sustainable level, below 75%.
View Smith & Nephew plc (SN.L)'s dividend history.

What price target have analysts set for SN?

9 brokerages have issued twelve-month price targets for Smith & Nephew plc (SN.L)'s stock. Their forecasts range from GBX 1,438 to GBX 1,975. On average, they expect Smith & Nephew plc (SN.L)'s share price to reach GBX 1,765.43 in the next year. This suggests a possible upside of 11.9% from the stock's current price.
View analysts' price targets for Smith & Nephew plc (SN.L)
or view Wall Street analyst' top-rated stocks.

Who are some of Smith & Nephew plc (SN.L)'s key competitors?

What other stocks do shareholders of Smith & Nephew plc (SN.L) own?

Who are Smith & Nephew plc (SN.L)'s key executives?

Smith & Nephew plc (SN.L)'s management team includes the following people:
  • Mr. Roland D. Diggelmann, Chief Exec. Officer (Age 53, Pay $1.49M)
  • Ms. Anne-Francoise Nesmes, CFO & Exec. Director (Age 49)
  • Mr. Mark Gladwell, Pres of Global Operations and Global Bus. Services (Age 45)
  • Mr. Andrew Swift, VP of Investor Relations
  • Ms. Catheryn O'Rourke, Chief Legal & Compliance Officer (Age 47)
  • Mr. Joe Metzger, Sr. VP of Marketing Services & Communications
  • Ms. Elga Lohler, Chief HR Officer (Age 52)
  • Mr. Philip G. Cowdy, Chief Bus. Devel. & Corp. Affairs Officer (Age 53)
  • Mr. Bradley Cannon, Pres of Sports Medicine & ENT (Age 52)
  • Dr. Vasant Padmanabhan, Pres of R&D (Age 53)

What is Smith & Nephew plc (SN.L)'s stock symbol?

Smith & Nephew plc (SN.L) trades on the London Stock Exchange (LON) under the ticker symbol "SN."

How do I buy shares of Smith & Nephew plc (SN.L)?

Shares of SN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Smith & Nephew plc (SN.L)'s stock price today?

One share of SN stock can currently be purchased for approximately GBX 1,577.

How big of a company is Smith & Nephew plc (SN.L)?

Smith & Nephew plc (SN.L) has a market capitalization of £13.83 billion and generates £4.69 billion in revenue each year. Smith & Nephew plc (SN.L) employs 17,500 workers across the globe.

What is Smith & Nephew plc (SN.L)'s official website?

The official website for Smith & Nephew plc (SN.L) is www.smith-nephew.com.

How can I contact Smith & Nephew plc (SN.L)?

Smith & Nephew plc (SN.L)'s mailing address is 15 Adam Street, LONDON, WC2N 6LA, United Kingdom. The company can be reached via phone at +44-20-74017646.

This page was last updated on 1/18/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.